-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on TransMedics Group, Lowers Price Target to $106

Benzinga·08/03/2026 10:26:54
语音播报
Needham analyst Mike Matson maintains TransMedics Group (NASDAQ:TMDX) with a Buy and lowers the price target from $142 to $106.